Abstract:Fetal cell microchimerism refers to the persistence of fetal cells in the maternal tissues following pregnancy. It has been detected in peripheral organs and the brain, but its existence in the spinal cord has not been reported. Our aim was to detect fetal cell microchimerism in the spinal cord of maternal mice. C57BL/6 female mice were crossed with GFP transgenic male mice and sacrificed after their first or third delivery. GFP-positive cells, which were presumably from fetuses whose fathers were GFP transgen… Show more
“…Fetal cells cross the placental barrier and enter the maternal circulation, where they can survive, migrate, and integrate into different maternal tissues ( Zeng et al., 2010 ). In animal models, FMc has been detected in various organs such as the bone marrow ( Fujiki et al., 2008 , 2009 ; Khosrotehrani et al., 2008 ; Pritchard et al., 2012 ), pituitary gland ( Jimenez et al., 2005 ), skin ( Jimenez et al., 2005 ; Aractingi et al., 2002 ), appendix ( Santos et al., 2008 ), liver ( Beksac et al., 2020 ; Fujiki et al., 2008 , 2009 ; Jimenez et al., 2005 ; Khosrotehrani et al., 2008 ; Wang et al., 2004 ), brain ( Dawe et al., 2007 ; Zeng et al., 2010 ; Tan et al., 2005 ), lung ( Fujiki et al., 2008 , 2009 ; Pritchard et al., 2012 ), heart ( Fujiki et al., 2008 , 2009 ; Jimenez et al., 2005 ; Kara et al., 2012 ), spinal cord ( Zhang et al., 2014 ), suprarenal gland ( Jimenez et al., 2005 ), kidney ( Fujiki et al., 2008 , 2009 ; Wang et al., 2004 ), spleen ( Fujiki et al., 2008 , 2009 ; Jimenez et al., 2005 ; Khosrotehrani et al., 2008 ), thyroid ( Imaizumi et al., 2002 ; Jimenez et al., 2005 ), lymph nodes ( Jimenez et al., 2005 ; Nguyen Huu et al., 2006 ), thymus ( Fujiki et al., 2008 , 2009 ; Khosrotehrani et al., 2008 ) and pancreas ( Vojdani et al., 2018 ) ( Figure 4 ). …”
Section: Detection and Characterization Of Fmc In Animal And Human Maternal Tissuesmentioning
Summary
There is a bidirectional transplacental cell trafficking between mother and fetus during pregnancy in placental mammals. The presence and persistence of fetal cells in maternal tissues are known as fetal microchimerism (FMc). FMc has high multilineage potential with a great ability to differentiate and functionally integrate into maternal tissue. FMc has been found in various maternal tissues in animal models and humans. Its permanence in the maternal body up to decades after delivery suggests it might play an essential role in maternal pathophysiology. Studying the presence, localization, and characteristics of FMc in maternal tissues is key to understanding its impact on the woman’s body. Here we comprehensively review the existence of FMc in different species and organs and tissues, aiming to better characterize their possible role in human health and disease. We also highlight several methodological considerations that would optimize the detection, quantification, and functional determination of FMc.
“…Fetal cells cross the placental barrier and enter the maternal circulation, where they can survive, migrate, and integrate into different maternal tissues ( Zeng et al., 2010 ). In animal models, FMc has been detected in various organs such as the bone marrow ( Fujiki et al., 2008 , 2009 ; Khosrotehrani et al., 2008 ; Pritchard et al., 2012 ), pituitary gland ( Jimenez et al., 2005 ), skin ( Jimenez et al., 2005 ; Aractingi et al., 2002 ), appendix ( Santos et al., 2008 ), liver ( Beksac et al., 2020 ; Fujiki et al., 2008 , 2009 ; Jimenez et al., 2005 ; Khosrotehrani et al., 2008 ; Wang et al., 2004 ), brain ( Dawe et al., 2007 ; Zeng et al., 2010 ; Tan et al., 2005 ), lung ( Fujiki et al., 2008 , 2009 ; Pritchard et al., 2012 ), heart ( Fujiki et al., 2008 , 2009 ; Jimenez et al., 2005 ; Kara et al., 2012 ), spinal cord ( Zhang et al., 2014 ), suprarenal gland ( Jimenez et al., 2005 ), kidney ( Fujiki et al., 2008 , 2009 ; Wang et al., 2004 ), spleen ( Fujiki et al., 2008 , 2009 ; Jimenez et al., 2005 ; Khosrotehrani et al., 2008 ), thyroid ( Imaizumi et al., 2002 ; Jimenez et al., 2005 ), lymph nodes ( Jimenez et al., 2005 ; Nguyen Huu et al., 2006 ), thymus ( Fujiki et al., 2008 , 2009 ; Khosrotehrani et al., 2008 ) and pancreas ( Vojdani et al., 2018 ) ( Figure 4 ). …”
Section: Detection and Characterization Of Fmc In Animal And Human Maternal Tissuesmentioning
Summary
There is a bidirectional transplacental cell trafficking between mother and fetus during pregnancy in placental mammals. The presence and persistence of fetal cells in maternal tissues are known as fetal microchimerism (FMc). FMc has high multilineage potential with a great ability to differentiate and functionally integrate into maternal tissue. FMc has been found in various maternal tissues in animal models and humans. Its permanence in the maternal body up to decades after delivery suggests it might play an essential role in maternal pathophysiology. Studying the presence, localization, and characteristics of FMc in maternal tissues is key to understanding its impact on the woman’s body. Here we comprehensively review the existence of FMc in different species and organs and tissues, aiming to better characterize their possible role in human health and disease. We also highlight several methodological considerations that would optimize the detection, quantification, and functional determination of FMc.
“…In one study, it has been de-monstrated that although the frequency of FSCs was higher in murine lungs during pregnancy, the number of fetal cells decreased significantly 21 days after delivery ( 18 ). In a recent study, GFP-positive cells were detected in 20% of the maternal spinal cord in first pregnancy; while it reached to 80% after the third pregnancy percent ( 19 ). Pregnancy-associated progenitor cells which have properties similar to stem cells and are found in injured and/or diseased tissues, persist in maternal blood and organs for decades after delivery ( 3 ).…”
Purpose:To identify the fetal stem cell (FSC) response to maternal renal injury with emphasis on renal integrity improvement and Y chromosome detection in damaged maternal kidney.Materials and Methods:Eight non-green fluorescent protein (GFP) transgenic Sprague-Dawley rats were mated with GFP-positive transgenic male rats. Renal damage was induced on the right kidney at gestational day 11. The same procedure was performed in eight non-pregnant rats as control group. Three months after delivery, right ne- phrectomy was performed in order to evaluate the injured kidney. The fresh perfused kidneys were stained with anti-GFP antibody. Polymerase chain reaction (PCR) assay was also performed for the Y chromosome detection. Cell culture was performed to detect the GFP-positive cells. Technetium-99m-DMSA renal scan and single-photon emission computed tomography (SPECT) were performed after renal damage induction and 3 months later to evaluate the improvement of renal integrity.Results:The presence of FSCs was confirmed by immune histochemical staining as well as immunofluorescent imaging of the damaged part. Gradient PCR of female rat purified DNA demonstrated the presence of Y-chromosome in the damaged maternal kidney. Moreover, the culture of kidney cells showed GPF- positive cells by immuno- fluorescence microscopy. The acute renal scar was repaired and the integrity of dam- aged kidney reached to near normal levels in experimental group as shown in DMSA scan. However, no significant improvement was observed in control group.Conclusion:FSC seems to be the main mechanism in repairing of the maternal renal injury during pregnancy as indicated by Y chromosome and GFP-positive cells in the sub-cultured medium.
“…(B) Murine models have demonstrated fetal placental cells traffic to injured maternal hearts and then give rise to cardiomyocytes, endothelial cells, and smooth muscle cells 56 . In addition, fetal chimeric cells have been reported to adopt diverse cell fates, including lymphocyte, 47 hepatocyte, 48 and neuron 45,46 …”
Section: Consequences and Functional Implicationsmentioning
confidence: 99%
“…The study demonstrated a potential for tissue repair and the possibility of identifying distinct subtypes within fetal microchimeric cells. Additionally, murine fetal microchimeric cells were detected in maternal spinal cord and brain tissue where they adopted neuronal phenotypes, 45,46 indicating that the cells can cross the blood–brain barrier. In murine brains with lesions or injury, fetal cells positioned themselves near blood vessels (but did not adopt an endothelial phenotype) and were found to express neuronal markers, suggesting tissue‐specific differentiation potential.…”
Section: Progress and Benefit Of Fetal Placental Progenitor Cells In mentioning
Organ and tissue repair are complex processes involving signaling molecules, growth factors, and cell cycle regulators that act in concert to promote cell division and differentiation at sites of injury. In embryonic development, progenitor fetal cells are actively involved in reparative mechanisms and display a biphasic interaction with the mother; and there is constant trafficking of fetal cells into maternal circulation and vice versa. This phenomenon of fetal microchimerism may have significant impact considering the primitive, multilineage nature of these cells. In published work, we have reported that fetal‐derived placental cells expressing the homeodomain protein CDX2 retain all “stem” functional proteins of embryonic stem cells yet are endowed with additional functions in areas of growth, survival, homing, and immune modulation. These cells exhibit multipotency in vitro and in vivo, giving rise to spontaneously beating cardiomyocytes and vascular cells. In mouse models, CDX2 cells from female placentas can be administered intravenously to male mice subjected to myocardial infarction with subsequent homing of the CDX2 cells to infarcted areas and evidence of cellular regeneration with enhanced cardiac function. Elucidating the role of microchimeric fetal‐derived placental cells may have broader scientific potential, as one can envision allogeneic cell therapy strategies targeted at tissue regeneration for a variety of organ systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.